4//SEC Filing
Yale Catriona 4
Accession 0001193125-25-268032
CIK 0001744659other
Filed
Nov 5, 7:00 PM ET
Accepted
Nov 6, 7:00 AM ET
Size
10.2 KB
Accession
0001193125-25-268032
Insider Transaction Report
Form 4
Yale Catriona
Chief Development Officer
Transactions
- Exercise/Conversion
Common Stock
2025-11-04$28.35/sh+3,527$99,990→ 70,061 total - Exercise/Conversion
Common Stock
2025-11-04$21.10/sh+4,739$99,993→ 74,800 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-11-04−4,739→ 0 totalExercise: $21.10Exp: 2031-12-07→ Common Stock (4,739 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2025-11-04−3,527→ 0 totalExercise: $28.35Exp: 2030-12-07→ Common Stock (3,527 underlying)
Footnotes (2)
- [F1]The reported amount has been adjusted to correct for an overstatement in the Reporting Person's previously reported common stock ownership.
- [F2]The options are vested and currently exercisable.
Documents
Issuer
Akero Therapeutics, Inc.
CIK 0001744659
Entity typeother
Related Parties
1- filerCIK 0001779308
Filing Metadata
- Form type
- 4
- Filed
- Nov 5, 7:00 PM ET
- Accepted
- Nov 6, 7:00 AM ET
- Size
- 10.2 KB